News

March 21, 2023

Knight Alzheimer Disease Research Center is increasing equity for African Americans

The WashU center has become a national model for building relationships and boosting diversity in clinical trials.

Outlook Magazine

March 8, 2023

Discovery of T cells’ role in Alzheimer’s, related diseases, suggests new treatment strategy

Findings, in mice, open up drug development possibilities for brain diseases linked to tau protein.

News Release

January 12, 2023

Gut bacteria affect brain health, mouse study shows

Findings suggest new approach to treating Alzheimer’s, other neurodegenerative diseases.

News Release

January 10, 2023

Sustainability key focus in Neuroscience Research Building construction

Facility on track to achieve LEED Gold certification.

Medical Campus & Community

December 5, 2022

Immunotherapy eliminates disease-causing cells in mice with MS-like disease

Successful cancer treatment approach extended to autoimmune disease.

News Release

November 24, 2022

Diagnostic marker found for deadly brain disease marked by dementia, movement problems

Discovery could accelerate progress toward therapies for primary tauopathies.

News Release

November 9, 2022

Rejuvenated immune cells can improve clearance of toxic waste from brain

Findings in mice suggest new therapeutic approach to Alzheimer’s, other age-related diseases.

News Release

October 25, 2022

Pediatric clinic for Rett syndrome draws patients for multispecialty care, clinical trials

Only such clinic for hundreds of miles.

Medical Campus & Community

October 17, 2022

Adeoye, Guilak, Gutmann, Kipnis elected to National Academy of Medicine

Election is one of the highest honors for contributions to health, medicine.

News Release

October 10, 2022

Research offers clues for treating fatal neurological disorder in kids

Enzyme replacement therapy, in mice and sheep, slowed brain degeneration.

News Release

September 30, 2022

Risk of Alzheimer’s dementia may be predicted with help of new tool

Demographic data, imaging results, biomarkers of study participants help determine risk.

News Release

September 21, 2022

Investigational drug for genetic form of ALS improves disease’s molecular signs

Extended use of tofersen may help stabilize muscle strength, control.

News Release

August 24, 2022

Study points to new approach to clearing toxic waste from brain

Could aid efforts to find treatments for Alzheimer’s, other diseases.

News Release

August 3, 2022

How deep sleep keeps our brains intact

WashU was first to reveal the intricate link between fragmented sleep and dementia.

Outlook Magazine

July 26, 2022

Shellhaas named associate dean for faculty promotions, career development

New position aims to boost efforts toward innovative career development.

News Release

July 22, 2022

Cruchaga named Morriss Professor

Studies genetic architecture of neurodegenerative diseases.

News Release

July 13, 2022

New center’s aim: to ID biomarkers of neurodegenerative diseases

Tracy Family SILQ Center to accelerate progress toward better diagnostics, treatments.

News Release

July 11, 2022

Neuroscience leaders tour research building construction site

Neuroscience Research Building’s 11 stories have been framed; siding installation has begun.

Medical Campus & Community

May 19, 2022

Epilepsy drug stops nervous system tumor growth in mice

Hyperactive neurons drive tumor growth in NF1 cancer predisposition syndrome.

News Release

April 21, 2022

Race of people given Alzheimer’s blood tests may affect interpretation of results

3 of 4 tests performed inconsistently across racial groups.

News Release